The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-benzyl-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanamide ID: ALA3092542
PubChem CID: 135549042
Max Phase: Preclinical
Molecular Formula: C18H17N3O2
Molecular Weight: 307.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CCc1nc2ccccc2c(=O)[nH]1)NCc1ccccc1
Standard InChI: InChI=1S/C18H17N3O2/c22-17(19-12-13-6-2-1-3-7-13)11-10-16-20-15-9-5-4-8-14(15)18(23)21-16/h1-9H,10-12H2,(H,19,22)(H,20,21,23)
Standard InChI Key: NTEGFXXGECYBTK-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
9.9576 -10.4996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9564 -11.3192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6645 -11.7281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6627 -10.0908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3713 -10.4960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3747 -11.3212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0871 -11.7286 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8006 -11.3154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7973 -10.4902 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0803 -10.0782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0758 -9.2611 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.5095 -11.7220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2161 -11.3115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9249 -11.7182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6315 -11.3077 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9271 -12.5354 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3403 -11.7143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0469 -11.3038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7515 -11.7129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4577 -11.3031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4559 -10.4850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7421 -10.0785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0389 -10.4907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 2 0
8 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 307.35Molecular Weight (Monoisotopic): 307.1321AlogP: 2.17#Rotatable Bonds: 5Polar Surface Area: 74.85Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.92CX Basic pKa: 5.40CX LogP: 1.74CX LogD: 1.75Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.76Np Likeness Score: -1.40
References 1. Lindgren AE, Karlberg T, Ekblad T, Spjut S, Thorsell AG, Andersson CD, Nhan TT, Hellsten V, Weigelt J, Linusson A, Schüler H, Elofsson M.. (2013) Chemical probes to study ADP-ribosylation: synthesis and biochemical evaluation of inhibitors of the human ADP-ribosyltransferase ARTD3/PARP3., 56 (23): [PMID:24188023 ] [10.1021/jm401394u ]